会议专题

The Estimation on the Innovation Performance of Manufacture of Medicines of China Based on the DEA-Benchmarking Model

  As an important high technology industry,Manufacture of medicines is developing fast and has a bright future.This paper presents an empirical analysis and a systemic evaluation on the manufacture of medicines innovation performance in China based on the provincial panel data of 2008 by using the DEA-Benchmarking model.Moreover,we try to show the feasibility and superiority for evaluating innovation performance using DEA-Benchmarking model based on the practical examples through comparing the results generated from different methods.

DEA model Manufacture of medicines Innovation performance Benchmarking management

Chong ZHANG Qinliang TAN

Renewable Energy School and State Key Laboratory of Alternate Electrical Power System with Renewable Economics and Management School North China Electric Power University Beijing,China

国际会议

2012 IEEE 5th International Conference on Management Engineering & Technology of Statistics (第五届(2012)管理工程与统计技术国际学术研讨会(ICMETS2012))

青岛

英文

684-689

2012-07-20(万方平台首次上网日期,不代表论文的发表时间)